Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy-a pilot study at 1.5 T

Neuroradiology

Volumn 52, Issue 2, 2010, Pages 91-97

  Kirsch, Eberhard C ^a   Kaim, Achim H ^a   De Oliveira, Marion Gregorio ^b   Von Arx, Georg ^c  

^a KLINIK HIRSLANDEN   (Switzerland)

^b UNIVERSITY EYE CLINIC   (Switzerland)

^c basedowch   (Switzerland)

Author keywords

Clinical activity score; Graves' orbitopathy; Magnetic resonance imaging; MRI turbo inversion recovery magnitude (MRI TIRM)

Indexed keywords

GADOLINIUM; GADOTERATE MEGLUMINE;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENDOCRINE OPHTHALMOPATHY; EXTRAOCULAR MUSCLE; FEMALE; HUMAN; MAGNETIC RESONANCE IMAGING TURBO INVERSION RECOVERY MAGNITUDE; MALE; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; TEMPORALIS MUSCLE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; FUNCTIONAL LATERALITY; GADOLINIUM; GRAVES OPHTHALMOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OCULOMOTOR MUSCLES; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77749249457     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-009-0590-z     Document Type: Article

References (23)

1. MP Mourits MF Prummel WM Wiersinga L Koornneef 1997 Clinical activityscore as a guide in the management of patients with Graves' ophthalmopathy Clin Endocrinol 47 9 14 10.1046/j.1365-2265.1997.2331047.x 1:STN:280:DyaK2svksl2htg%3D%3D
2. MN Gerding MF Prummel WM Wiersinga 2000 Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters Clin Endocrinol 52 641 646 10.1046/j.1365-2265.2000.00973.x 1:STN:280: DC%2BD3c3lt12qtQ%3D%3D (Pubitemid 30337091)
3. Young IR, Bydder GM, Hajnal JV (1997) Contrast properties of the inversion recovery sequence. In: Bradley WG Jr, Bydder GM (eds) Advanced MR Imaging Techniques. Martin Dunitz Ltd, London, pp 143-162
4. European Group on Graves' Orbitopathy (EUGOGO) WM Wiersinga P Perros GJ Kahaly MP Mourits L Baldeschi K Boboridis A Boschi AJ Dickinson P Kendall-Taylor GE Krassas CM Lane JH Lazarus C Marcocci M Marino M Nardi C Neoh J Orgiazzi A Pinchera S Pitz MF Prummel MS Sartini M Stahl G von Arx 2006 Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers Eur J Endocrinol 155 387 389 10.1530/eje.1.02230 1:CAS:528:DC%2BD28XhtVClur%2FN 16914591 (Pubitemid 44463943)
5. E Chang MW Wilson ME Smith 2002 Orbital Imaging in Thyroid Eye Disease.In: Dutton JJ, Haik BG.Thyroid Eye Disease Diagnosis and Treatment 30 301 308
6. L Bartalena WM Wiersinga A Pinchera 2004 Graves' ophthalmopathy: state of the art and perspectives J Endocrinol Invest 27 295 301 1:STN:280: DC%2BD2c3ms1Kmtg%3D%3D 15165007
7. M Salvi D Dazzi I Pellistri F Neri JR Wall 2002 Classification and prediction of the progression of thyroid-associated ophthalmopathy by an artificial neural network Ophthalmology 109 1703 1708 10.1016/S0161-6420(02) 01127-2 12208720 (Pubitemid 35006403)
8. A Eckstein M Plicht H Lax M Neuhäuser K Mann S Lederbogen C Heckmann J Esser NG Morgenthaler 2006 Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease J Clin Endocrinol Metab 91 3464 3470 10.1210/jc.2005-2813 1:CAS:528:DC%2BD28XpslajtLk%3D 16835285 (Pubitemid 44402120)
9. AK Eckstein H Lax C Lösch D Glowacka M Plicht K Mann J Esser NG Morgenthaler 2007 Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission Clin Endocrinol (Oxf) 67 607 612
10. D Noth M Gebauer B Müller U Bürgi P Diem 2001 Graves' ophthalmopathy: natural history and treatment outcomes Swiss Med Wkly 131 603 609 1:STN:280:DC%2BD38%2FptFKquw%3D%3D 11820071
11. N Takasu K Yamashiro I Komiya Y Ochi Y Sato A Nagata 2000 Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment Thyroid 10 891 896 10.1089/thy.2000.10.891 1:CAS:528: DC%2BD3cXos1Okt78%3D 11081255
12. MC Villadolid N Yokoyama M Izumi T Nishikawa H Kimura K Ashizawa T Kiriyama M Uetani S Nagataki 1995 Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance J Clin Endocrinol Metab 80 2830 2833 10.1210/jc.80.9.2830 1:CAS:528:DyaK2MXotFyiurg%3D 7673432
13. T Ohnishi S Noguchi N Murakami J Tajiri M Harao H Kawamoto H Hoshi S Jinnouchi S Futami S Nagamachi 1994 Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements Radiology 190 857 862 1:STN:280:DyaK2c7lvFyrtQ%3D%3D 8115640 (Pubitemid 24071060)
14. D Pauleit H Schüller J Textor C Leutner E Keller T Sommer F Träber W Block I Boldt H Schild 1997 MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy ROFO 167 557 564 1:STN:280:DyaK1c7islSqtQ%3D%3D 9465949
15. RD Laitt B Hoh C Wakely J Kabala R Harrad M Potts 1994 The value of the short tau inversion recovery sequence in magnetic resonance imaging of thyroid eye disease Br J Radiol 67 244 247 10.1259/0007-1285-67-795-244 1:STN:280:DyaK2c7nslequg%3D%3D 8130995
16. Y Amano M Amano T Kumazaki 1997 Normal contrast enhancement of extraocular muscles: fat-suppressed MR findings Am J Neuroradiol 18 161 164 1:STN:280:DyaK2s7mtlOhug%3D%3D 9010535
17. TM Link P Reimer EJ Rummeny G Schuierer U Grenzebach PE Peters 1995 The MRT of the orbit: the value of T1-weighted frequency-selective fat saturation at 1.0 and 1.5 tesla ROFO 163 406 410 1:STN:280:DyaK28%2FpslWkuw%3D%3D 8527754
18. S Cakirer D Cakirer M Basak S Durmaz Y Altuntas U Yigit 2004 Evaluation of extraocular muscles in the edematous phase of Graves ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging J Comput Assist Tomogr 28 80 86 10.1097/00004728-200401000-00013 14716237 (Pubitemid 38057859)
19. B Yanik I Conkbayir G Acaroglu B Hekimoglu 2005 Graves' ophthalmopathy: comparison of the Doppler sonography parameters with the clinical activity score J Clin Ultrasound 33 375 380 10.1002/jcu.20154 16240428 (Pubitemid 41540985)
20. MN Alp A Ozgen I Can P Cakar I Gunalp 2000 Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation Br J Ophthalmol 84 1027 1030 10.1136/bjo.84.9.1027 1:STN:280:DC%2BD3cvotVKgsQ%3D%3D 10966959
21. M Ott N Breiter CF Albrecht O Pradier CF Hess H Schmidberger 2002 Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy? Br J Radiol 75 514 517 1:STN:280:DC%2BD38znvVWmsw%3D%3D 12124238
22. T Taoka M Sakamoto H Nakagawa A Fukusumi S Iwasaki K Taoka K Kichikawa 2005 Evaluation of extraocular muscles using dynamic contrast enhanced MRI in patients with chronic thyroid orbitopathy J Comput Assist Tomogr 29 115 120 10.1097/01.rct.0000146112.56194.24 15665696 (Pubitemid 40194451)
23. EJ Mayer DL Fox G Herdmann J Hsuan J Kabala P Goddard MJ Potts RWJ Lee 2005 Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease Eur J Radiol 56 20 24 10.1016/j.ejrad.2005.03.027 1:STN:280:DC%2BD2MvpslWgtQ%3D%3D 15896938 (Pubitemid 41316481)